Immunocore Holdings (IMCR) Capital Expenditures Growth (3y) (2024 - 2026)

Immunocore Holdings (IMCR) Capital Expenditures Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Oculis Holding AG 66,440.76 Bn 66,440.47 Bn - -
2 Nanobiotix 1,909.20 Bn 1,909.14 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
4 BeOne Medicines 468.28 Bn 463.49 Bn 1.35 Bn -12.25%
5 Vertex Pharmaceuticals 122.49 Bn 115.24 Bn 2.59 Bn 46.88%
6 Regeneron Pharmaceuticals 70.26 Bn 61.51 Bn 3.31 Bn 8.97%
7 Belite Bio 62.88 Bn 62.88 Bn - -
8 Argenx Se 55.67 Bn 50.48 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn 16.27%
10 Immunocore Holdings 1.77 Bn 922.13 Mn 106.24 Mn -15.96%

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.96%
Dec 31, 2025 38.81%
Sep 30, 2025 17.22%
Dec 31, 2024 112.26%